NORRINGTON LORRIE M 4

What Happened

• Lorrie M. Norrington, a director of Colgate-Palmolive Co. (CL), received two awards on May 11, 2026: 2,075 shares credited as stock units and a derivative award of 2,424 stock options. Both grants were recorded at $0 cash outlay to the insider (typical for compensation grants).

Key Details

• Transaction dates and filing: Grants dated May 11, 2026; Form 4 filed May 13, 2026 (timely filing covering the May 11 award).
• Prices/values: Both awards reported at $0 (standard for equity compensation grants); not proceeds from a market transaction.
• Vesting/derivative specifics: The 2,424-share derivative is an annual director stock option grant. Per the filing, the option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.
• Shares owned after transaction: Not disclosed in the filing.
• Footnotes: F1 = stock units credited to a stock unit account under the incentive compensation plan; F2 = annual director stock option grant; F3 = three-year vesting schedule for the option.
• Timeliness: Filing appears timely (filed two days after the grant date).

Context

• These awards are routine director compensation and do not represent an open-market purchase or sale. Equity grants and options are commonly used to align directors’ interests with shareholders; they are not direct indicators of buy/sell sentiment. The option's multi-year vesting means any future economic benefit depends on continued service and potential future exercises.